CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/20/2020
Back to search
Official data from USPTO
PHARMASTAT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMASTAT
ST13
US500000078392731Class
35, 42
Filing
78392731
Registration
3348047
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
66
Latest update
10/20/2020
Trademark type
Word
Nice classes
35, 42
Filing date
03/29/2004
Registration date
12/04/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/05/2017
Last transaction
07/05/2017
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
03/11/2002
First use in commerce
03/04/2003
Drawing code
4
Owner type
16
Owner location
Fremont, CA
Examiner
ERVIN, INGA
Law office
M20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
PharmaStat LLC
PharmaStat LLC
Representatives
Elizabeth J. Rest Crown, LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting services and project management services for others in the field of pharmaceutical drug development; business research servicesproviding biostatistical analysisreports and business data monitoring in the field of pharmaceutical drug development; database management consulting services for others in the field of pharmaceutical drug development
Class 42
Pharmaceutical drug development program services; technology consultation in the field of pharmaceutical drug development; business document preparation for others to meet government regulations in the field of pharmaceutical drug development
Publications
History of USPTO decisions and trademark events.
66 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/20/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/20/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/20/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/20/2020
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
06/17/2020
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
06/17/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/16/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/16/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/16/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/16/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/16/2020
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/05/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/05/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/05/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/27/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
05/17/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/04/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/16/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/16/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/13/2013
E815
TEAS SECTION 8 & 15 RECEIVED
03/28/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
12/04/2007
PUBO
PUBLISHED FOR OPPOSITION
09/18/2007
NPUB
NOTICE OF PUBLICATION
08/29/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/16/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/13/2007
XAEC
EXAMINER'S AMENDMENT ENTERED
07/06/2007
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/06/2007
GNEA
EXAMINERS AMENDMENT E-MAILED
07/06/2007
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/06/2007
GNRT
NON-FINAL ACTION E-MAILED
06/08/2007
CNRT
NON-FINAL ACTION WRITTEN
06/08/2007
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/08/2007
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
06/02/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/24/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/19/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/28/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/28/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/27/2007
GNSI
INQUIRY TO SUSPENSION E-MAILED
03/22/2007
CNSI
SUSPENSION INQUIRY WRITTEN
03/22/2007
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/29/2007
ALIE
ASSIGNED TO LIE
01/29/2007
GNSL
LETTER OF SUSPENSION E-MAILED
07/14/2006
CNSL
SUSPENSION LETTER WRITTEN
07/14/2006
GNRT
NON-FINAL ACTION E-MAILED
05/03/2006
CNRT
NON-FINAL ACTION WRITTEN
05/03/2006
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/11/2006
GNSL
LETTER OF SUSPENSION E-MAILED
09/06/2005
CNSL
SUSPENSION LETTER WRITTEN
09/06/2005
XAEC
EXAMINER'S AMENDMENT ENTERED
08/16/2005
GNEA
EXAMINERS AMENDMENT E-MAILED
08/15/2005
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/15/2005
GNRT
NON-FINAL ACTION E-MAILED
03/23/2005
CNRT
NON-FINAL ACTION WRITTEN
03/23/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
03/03/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/24/2005
PAPER RECEIVED
01/24/2005
GNRT
NON-FINAL ACTION E-MAILED
10/15/2004
CNRT
NON-FINAL ACTION WRITTEN
10/15/2004
DOCK
ASSIGNED TO EXAMINER
10/15/2004
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/17/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/17/2004
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/17/2004
NWAP
NEW APPLICATION ENTERED
04/06/2004
Continuous trademark protection
Get notified about every new filing that threatens PHARMASTAT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.